{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T15:49:21Z","timestamp":1771256961016,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.adro.2025.101822","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T19:21:06Z","timestamp":1749237666000},"page":"101822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Salvage Irradiation for Ocular Adnexal Mucosa Associated Lymphoid Tissue Lymphoma Refractory to Chlamydia psittaci Eradication"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8397-7207","authenticated-orcid":false,"given":"Elena","family":"Flospergher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Sassone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Chiara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Marino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Giordano","family":"Resti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurilio","family":"Ponzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Giulia","family":"Cangi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Bongiovanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilda","family":"Magliacane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Modorati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Miserocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Calimeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piera","family":"Angelillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Erbella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s J.M.","family":"Ferreri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2025.101822_bib0001","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.beha.2016.11.002","article-title":"Ocular adnexal marginal zone lymphoma: Clinical presentation, pathogenesis, diagnosis, prognosis, and treatment","volume":"30","author":"Sassone","year":"2017","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.adro.2025.101822_bib0002","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/bjc.2012.2","article-title":"Exposure to animals and increased risk of marginal zone B-cell lymphomas of the ocular adnexae","volume":"106","author":"Dolcetti","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.adro.2025.101822_bib0003","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/ijc.23596","article-title":"Chlamydophila psittaci is viable and infectious in the conjunctiva and peripheral blood of patients with ocular adnexal lymphoma: Results of a single-center prospective case-control study","volume":"123","author":"Ferreri","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.adro.2025.101822_bib0004","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/CAD.0b013e32830b58c4","article-title":"Variable association between Chlamydophila psittaci infection and ocular adnexal lymphomas: Methodological biases or true geographical variations?","volume":"19","author":"Decaudin","year":"2008","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.adro.2025.101822_bib0005","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nrclinonc.2009.147","article-title":"Chlamydial infection: The link with ocular adnexal lymphomas","volume":"6","author":"Ferreri","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.adro.2025.101822_bib0006","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/hon.921","article-title":"Geographic variation and environmental conditions as cofactors in Chlamydia psittaci association with ocular adnexal lymphomas: A comparison between Italian and African samples","volume":"28","author":"Carugi","year":"2010","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.adro.2025.101822_bib0007","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/path.1984","article-title":"Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions","volume":"209","author":"Chanudet","year":"2006","journal-title":"J Pathol"},{"key":"10.1016\/j.adro.2025.101822_bib0008","article-title":"Evidence for association between Chlamydia psittaci infection and ocular adnexal lymphoma (OAL)","volume":"22","author":"Ferreri","year":"2003","journal-title":"Proc Annu Meet Am Soc Clin Oncol"},{"key":"10.1016\/j.adro.2025.101822_bib0009","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/ajh.20962","article-title":"Chlamydia psittaci infection and clinicopathologic analysis of ocular adnexal lymphomas in Korea","volume":"82","author":"Yoo","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.adro.2025.101822_bib0010","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/annonc\/mdm484","article-title":"Infectious disease associations in advanced stage, indolent lymphoma (follicular and nonfollicular): Developing a lymphoma prevention strategy","volume":"19","author":"Portlock","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.adro.2025.101822_bib0011","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1158\/1078-0432.CCR-08-0676","article-title":"Chlamydia infection and lymphomas: Association beyond ocular adnexal lymphomas highlighted by multiple detection methods","volume":"14","author":"Ponzoni","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.adro.2025.101822_bib0012","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.leukres.2007.10.013","article-title":"Chlamydia psittaci in MALT lymphomas of ocular adnexals: The Austrian experience","volume":"32","author":"Aigelsreiter","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.adro.2025.101822_bib0013","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1200\/JCO.2011.41.4466","article-title":"Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: Final results of an international phase II trial","volume":"30","author":"Ferreri","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2025.101822_bib0014","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/jnci\/djj373","article-title":"Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: A multicenter prospective trial","volume":"98","author":"Ferreri","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.adro.2025.101822_bib0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.annonc.2019.10.010","article-title":"Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Zucca","year":"2020","journal-title":"Ann Oncol"},{"issue":"suppl 1","key":"10.1016\/j.adro.2025.101822_bib0016","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.1182\/blood-2022-168712","article-title":"Six-month doxycycline is safe and effective as upfront monotherapy for stage-I MALT lymphoma of the ocular adnexae: Primary endpoint results of the IELSG39 trial","volume":"140","author":"Ferreri","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.adro.2025.101822_bib0017","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2025.101822_bib0018","doi-asserted-by":"crossref","first-page":"e659","DOI":"10.1016\/j.ijrobp.2011.03.050","article-title":"Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: Efficacy and toxicity","volume":"81","author":"Goda","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2025.101822_bib0019","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2141.2010.08429.x","article-title":"Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): Single institution experience in a large cohort of patients","volume":"152","author":"Bayraktar","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.adro.2025.101822_bib0020","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.ijrobp.2011.04.052","article-title":"Long-term outcome and patterns of failure in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy","volume":"82","author":"Hashimoto","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2025.101822_bib0021","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13014-020-1477-8","article-title":"Radiotherapy alone for stage IE ocular adnexal mucosa-associated lymphoid tissue lymphomas: Long-term results","volume":"15","author":"Niwa","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2025.101822_bib0022","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/cncr.11539","article-title":"Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: A multiinstitutional, retrospective review of 50 patients","volume":"98","author":"Uno","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.adro.2025.101822_bib0023","first-page":"15","article-title":"Radiation therapy for primary orbital and ocular adnexal lymphoma","volume":"38","author":"Pereira-Da Silva","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.adro.2025.101822_bib0024","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1470-2045(20)30686-0","article-title":"4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (Fort): Long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial","volume":"22","author":"Hoskin","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2025.101822_bib0025","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.ijrobp.2013.04.035","article-title":"Low-dose radiation therapy (2 Gy x 2) in the treatment of orbital lymphoma","volume":"86","author":"Fasola","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2025.101822_bib0026","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2024.2112","article-title":"Response-adapted ultralow-dose radiation therapy for orbital indolent B-cell lymphoma: A phase 2 nonrandomized controlled trial","volume":"10","author":"Pinnix","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.adro.2025.101822_bib0027","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1002\/cam4.5237","article-title":"Watchful waiting is an acceptable treatment option for asymptomatic primary ocular adnexal mucosa-associated lymphoid tissue lymphoma: A retrospective study","volume":"12","author":"Mizuhara","year":"2023","journal-title":"Cancer Med"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109425001095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109425001095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T14:39:55Z","timestamp":1757687995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109425001095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2452109425001095"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2025.101822","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salvage Irradiation for Ocular Adnexal Mucosa Associated Lymphoid Tissue Lymphoma Refractory to Chlamydia psittaci Eradication","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2025.101822","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101822"}}